Carvedilol Drug Market Share

On the basis of geographical analysis, the global carvedilol drug market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in the Asia Pacific industry is likely to account for largest revenue share by 2036, driven by rising prevalence of hypertension in low and middle income countries. As per a WHO report, two-third of the total hypertension cases occur in low- and middle-income countries.

The carvedilol drug market in the North America region is anticipated to gain the largest revenue share throughout the forecast period owing to the high prevalence of heart failure and high blood pressure, along with the presence of efficient healthcare infrastructure in the region. According to the data by the Center for Disease Control and Prevention (CDC), heart failure was the cause for 379,800 deaths in 2018. Moreover, 116 million adults have hypertension in the United States.